Return to Current Pharmacy Preceptors
Oncology Pharmacist
Rotation Precepted
PGY 1 and PGY2 Inpatient Heme/BMT
Pharmacy School/Graduation Year
University of Wisconsin Madison, 2007
Residency Training Program Location/Year
Froedtert Hospital, 2008
Professional Interests
Malignant Hematology, Bone Marrow Transplant, Cellular therapy
Organizational Involvement
- Clinical Trials Network (CTN) Pharmacy Committee
- CRS/CRES (Cellular Therapy) Committee
- Oncology/Hematology Inpatient Service Line Committee
- HOPA Oncology Workforce Collaborative
- Pharmacy Research Committee
Awards/Certifications
Board Certified Oncology Pharmacist
Recent Publications/Posters
- Zurko JC, Johnson BD, Aschenbrenner E, et al. JAMA Oncol. Research Letter. March 10, 2022. Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome.
- Furqan F, Aschenbrenner E, Talano J, Moskop A, Longo W, Johnson B, Fenske T, Hamadani M, Shah N. Clinical Characteristics and Patient Outcomes with HLH-like Toxicities after CD19 Based CAR T-Cell Therapy. American Society of Transplantation and Cellular Therapy Annual Conference. February 2023.
- Nelson M, Aschenbrenner E, Lorge A, Daniels A, Jerkins J. Risk Factors for Vancomycin-Associated Nephrotoxicity in the Hematopoietic Stem Cell Transplant (HSCT) Population. American Society of Transplantation and Cellular Therapy Annual Conference. February 2021.
- Rezazadeh A, George G, Pearl N, McCoy C, Aschenbrenner E, Zook F, Waggoner M, Jung B, Baumann- Kreuziger L, Runaas L, Abedin S, Carlson K, Michaelis L, Atallah E. Reducing Venous Thrombosis with Antithrombin Supplementation in Adult Patients Undergoing Treatment for ALL with Asparaginase-based Therapy. American Society of Hematology Annual Conference. December 2018.
Projects
BiTE Therapy CRS/ICANS resident project and guideline development
Hobbies
Pilates, travel, classical music, paddle boarding, spending time on the lake in summer, snowshoeing in the winter